Elly Lee
Psychiatry · Irvine, CANPI 1508156316
Payments from drug & device makers
What this record shows
13 manufacturers reported payments, led by Merck at 26.7% of the total. 2025 is the largest year on record at $5,068, more than ten times the $355 reported in 2019. Among psychiatry clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 46 payments — averaging $140.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$2K
- Roche Products Limited$2K
- Neurocrine Biosciences, Inc.$1K
- Biogen$823
- Genentech USA, Inc.$150
- Eisai Inc.$126
- plus $483 from 7 others
Across 730 payments — averaging $68,482 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$38.4M
- AbbVie$3.8M
- Janssen Research & Development, LLC$1.8M
- Eisai Inc.$1.7M
- Biogen$1.5M
- Novartis$784K
- plus $1.9M from 11 others
What the payments were for
- Travel & lodging$3,06147%
- Food & beverage$3,39553%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 11 | $1,724 |
| Roche Products Limited | 3 | $1,708 |
| Neurocrine Biosciences, Inc. | 12 | $1,441 |
| Biogen | 10 | $823 |
| Genentech USA, Inc. | 1 | $150 |
| Eisai Inc. | 2 | $126 |
| E.r. Squibb & Sons, L.L.C. | 1 | $116 |
| Eli Lilly | 1 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $99 |
| F. Hoffmann-la Roche AG | 1 | $80 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $28 |
| UCB SA | 1 | $26 |
| Novartis | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ADUHELM$134
How this compares
$6,456 in reported general payments places this provider in the 90th percentile of 4,954 psychiatry providers in California.
Other psychiatry in Irvine
- Jason KelloggIrvine$2.7M
- Charles Tuan-Tu NguyenIrvine$2.1M
- Gustavo AlvaOrange$5.8M
- John KooSan Francisco$3M
- Jonathan MeyerSan Diego$2.3M
- Manoj WaikarLos Gatos$1.9M
- Gerald MaguireSan Juan Capistraco$1.8M
- Salima BrillmanSunnyvale$1.4M
- Bibi DasStanford$1.4M
- Konstantinos TripodisBurbank$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.